Embecta Corp. (EMBC) stock
EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3080% below fair value
$6.25−0.21 (-3.25%)
Close on Nov 16, 2026Market cap $354.12MP/E 4.3Yield 9.60%
Embecta pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Embecta's pe ratio was 4.4× on Nov 11, 2026, against 7.9× a year earlier. Over the last 5 years it ranged from 1.7× to 22.9×, with a median of 10.2×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.4× | −2.9 |
| 2025 | Dec 31, 2025 | 7.3× | −8.1 |
| 2024 | Dec 31, 2024 | 15.4× | −0.1 |
| 2023 | Dec 29, 2023 | 15.5× | +9.0 |
| 2022 | Dec 30, 2022 | 6.5× | – |
See a number that looks wrong?